Novartis Expects Further Profit, Sales Growth Despite Competition Threat
The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...
Novartis beats Q4 earnings consensus as drug sales surge
Novartis on Friday posted adjusted net income well above analyst estimates as sales of established heart failure drug ...
Novartis Expects Further Profit, Sales Growth Despite Competition Threat — 2nd Update
Novartis said Friday that it expects core operating profit--one of its preferred metrics, which strips out exceptional items--for 2025 to grow in the high-single-digit to low-double-digit range and ...
Novartis AG: Balancing Strong Performance with Future Challenges – Hold Rating Maintained
In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Hold rating on Novartis AG (NOVN – Research Report), with a ...
Procurement Software Market Valuation is Poised to Surpass US$ 17.87 Billion by 2033 | Astute Analytica
Procurement software demand is driven by digital transformation, AI, and sustainability, with key players like SAP Ariba and ...
FTSE 100 LIVE: London's top index headed for best month in nearly three years
Smiths Group propped up the FTSE 100, rising more than 14% after the opening bell following news it had responded to activist investor calls to split up its business.